
    
      This is a 14 week randomized open study of 50 inpatients or outpatients with bipolar I r II.
      African American subjects will receive lithium or depakote ER. Measures will be made of
      psychopathology, reported side effects, and study completers. Measures will also be made of
      RBC/plasma lithium to determine if this level is better predictive of lithium tolerability.
    
  